Evidence map›Paper›PMID 35691580›Full record

ArticleOphthalmology. Retina2022

The Prevalence of Retinal Disease and Associated CNS Disease in Young Patients with Incontinentia Pigmenti.

Ian D Danford, Brittni A Scruggs, Antonio Capone, Michael T Trese, Kim A Drenser, Aristomenis Thanos, Eric Nudleman, Atchara Amphornphruet, Boontip Tipsuriyaporn, G Baker Hubbard and 21 more

Open access · greenAbstract read
In one paragraph

Article in Ophthalmology. Retina, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.9field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Ectodermal Dysplasia - An Overview and Update.Indian dermatology online journal
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

31 authors at 16 institutions in 3 countries.

Ian D DanfordCasey Eye Institute, Oregon Health and Science University, Portland, Oregon.
Brittni A ScruggsCasey Eye Institute, Oregon Health and Science University, Portland, Oregon; Department of Ophthalmology, Mayo Clinic, Rochester, Minnesota.
Antonio CaponeAssociated Retinal Consultants, PC, Royal Oak, Michigan.
Michael T TreseAssociated Retinal Consultants, PC, Royal Oak, Michigan.
Kim A DrenserAssociated Retinal Consultants, PC, Royal Oak, Michigan.
Aristomenis ThanosAssociated Retinal Consultants, PC, Royal Oak, Michigan; Legacy Devers Eye Institute, Portland, Oregon.
Eric NudlemanAssociated Retinal Consultants, PC, Royal Oak, Michigan; Shiley Eye Institute, University of California, San Diego, La Jolla, California.
Atchara AmphornphruetQueen Sirikit National Institute of Child Health, Department of Ophthalmology, Bangkok, Thailand.
Boontip TipsuriyapornQueen Sirikit National Institute of Child Health, Department of Ophthalmology, Bangkok, Thailand.
G Baker HubbardEmory Eye Center, Emory University, Atlanta, Georgia.
Anna EllsCalgary Retina Consultants, Calgary, Alberta, Canada.
C Armitage HarperAustin Retina Associates, Austin, Texas.
Jessica GoldsteinAustin Retina Associates, Austin, Texas.
Charles CalvoRetina Consultants of Nevada, Las Vegas, Nevada.
Chris Wallace-CarreteJohn A. Moran Eye Center, University of Utah, Salt Lake City, Utah.
Duncan BerryCharlotte Eye, Ear, Nose & Throat Associates, P.A., Charlotte, North Carolina.
Emmanuel ChangRetina and Vitreous of Texas, Houston, Texas.
Lisa LeishmanRetina Consultants, Ltd., Des Plaines, Illinois.
Michael ShapiroRetina Consultants, Ltd., Des Plaines, Illinois.
Michael BlairRetina Consultants, Ltd., Des Plaines, Illinois.
Mikel MikhailLakeridge Health, Queen's University, Ontario, Canada.
Carol L ShieldsOcular Oncology Service, Wills Eye Hospital, Sidney Kimmel Medical College of Thomas Jefferson University Philadelphia, Pennsylvania.
Rachel SchwendemanOcular Oncology Service, Wills Eye Hospital, Sidney Kimmel Medical College of Thomas Jefferson University Philadelphia, Pennsylvania.
Yoshihiro YonekawaMid Atlantic Retina, Wills Eye Hospital, Sidney Kimmel Medical College of Thomas Jefferson University, Philadelphia, Pennsylvania.
Mrinali P GuptaRetina Associates of Orange County, Laguna Hills, California; Weill Cornell Medical College, New York, New York.
Anton OrlinWeill Cornell Medical College, New York, New York.
Supalert PrakhunhungsitFaculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand.
Shizuo MukaiMassachusetts Eye and Ear Infirmary, Harvard University, Boston, Massachusetts.
Audina BerrocalBascom Palmer Eye Institute, Department of Ophthalmology, University of Miami, Miami, Florida.
M Elizabeth HartnettJohn A. Moran Eye Center, University of Utah, Salt Lake City, Utah.
J Peter CampbellCasey Eye Institute, Oregon Health and Science University, Portland, Oregon. Electronic address: campbelp@ohsu.edu.
Associated Retinal Consultants · USCalifornia Retina Consultants · USOregon Health & Science University · USWills Eye Hospital · USCornell University · USQueen Sirikit National Institute of Child Health · THTexas Retina Associates (United States) · USUniversity of Utah · USCharlotte Eye Ear Nose & Throat Associates · USEmory University · USLegacy Health · USMassachusetts Eye and Ear Infirmary · USQueen's University · CARetina Consultants of Texas · USSiriraj Hospital · THUniversity of Miami · US

Funding

Proteomics CoreP30EY010572 · NEI · OREGON HEALTH & SCIENCE UNIVERSITY · PI TED S ACOTT · 1995 to 2026
$19.4M
Mechanisms of Angiogenesis of Retinopathy of PrematurityR01EY015130 · NEI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Mary Elizabeth Ruth Hartnett · 2005 to 2026
$7.6M
Clinical and Genetic Analysis of Retinopathy of PrematurityR01EY019474 · NEI · OREGON HEALTH & SCIENCE UNIVERSITY · PI CAMPBELL, JOHN PETER · 2010 to 2020
$7.0M
Artificial Intelligence Assisted Panoramic Optical Coherence Tomography Angiography for Retinopathy of PrematurityR01HD107494 · NICHD · OREGON HEALTH & SCIENCE UNIVERSITY · PI John Peter Campbell, Yifan Jian · 2021 to 2026
$2.4M
Clinical and genetic analysis of retinopathy of prematurityR01HD107493 · NICHD · OREGON HEALTH & SCIENCE UNIVERSITY · PI CAMPBELL, JOHN PETER · 2021 to 2023
$1.8M
Artificial intelligence assisted panoramic Optical Coherence Tomography Angiography for Retinopathy of PrematurityR01EY031331 · NEI · OREGON HEALTH & SCIENCE UNIVERSITY · PI CAMPBELL, JOHN PETER, JIAN, YIFAN · 2020 to 2020
$342k
NEI NIH HHS P30 EY010572NEI NIH HHS R01 EY015130NEI NIH HHS R01 EY019474NEI NIH HHS R01 EY031331NICHD NIH HHS R01 HD107493NICHD NIH HHS R01 HD107494
6 · The paper itself

Abstract

purposeTo evaluate the prevalence of retinal disease on fluorescein angiography (FA) in patients with incontinentia pigmenti (IP) and to compare the severity of retinal disease in those with and without known central nervous system (CNS) disease.

designMulti-institutional consecutive retrospective case series. SUBJECTS: New patients with a diagnosis of IP were seen at the Casey Eye Institute at the Oregon Health and Science University (OHSU), Moran Eye Center, University of Utah, or Bascom Palmer Eye Institute, University of Miami from December 2011 to September 2018.

methodsDetailed ophthalmoscopic examination and FA were recommended for all new patients and performed on every patient who had parental consent. Ophthalmoscopic findings and FA images were graded for severity by 2 masked graders on a 3-point scale: 0 = no disease, 1 = vascular abnormalities without leakage, 2 = leakage or neovascularization, and 3 = retinal detachment. The presence of known CNS disease was documented. Additional cases were obtained from a pediatric retina listserv for examples of phenotypic variation.

main outcome measuresThe proportion of eyes noted to have disease on ophthalmoscopy compared with FA and the severity of retinal disease in those with and without known CNS disease.

resultsRetinal pathology was detected in 18 of 35 patients (51%) by indirect ophthalmoscopy and 26 of 35 patients (74%) by FA (P = 0.048) in a predominantly pediatric population (median age, 9 months). Ten patients (29%) had known CNS disease at the time of the eye examination. A Wilcoxon rank-sum test indicated that the retinal severity scores for patients with CNS disease (median, 2) were significantly higher than the retinal severity scores for patients without CNS disease (median, 1), z = -2.12, P = 0.034.

conclusionsRetinal disease is present in the majority of patients with IP, and ophthalmoscopic examination is less sensitive than FA for detection of disease. There may be a correlation between the severity of retinal and CNS disease.

Indexed as

Central Nervous System DiseasesIncontinentia PigmentiRetinal DiseasesChildHumansInfantPrevalenceRetinaRetrospective StudiesCNS diseaseFluorescein angiographyIncontinentia pigmentiRetinopathy

Identifiers

PMID35691580
PMCPMC10278150
OpenAlexW4281741253

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.